Precision Cancer Medicine

Activities

Activities per year 1998 2016 2018 2019 2020 2021 2023

• 106 Oral conference presentations and other invited talks
• 87 Other
• 69 Publication peer-review
• 69 Membership of committee
• 182 More
  • 50 Membership of funding review panel
  • 27 Membership of network
  • 21 Consumer Engagement
  • 19 Invited Keynote and Plenary Presentations
  • 15 Editorial Board Role
  • 14 Organising a conference
  • 11 Participation in conference
  • 9 Membership of board
  • 6 Examination
  • 4 Consultancy and providing expertise
  • 3 Organising a workshop, seminar, course
  • 2 Participation in workshop, seminar, course
  • 1 Visiting an external academic institution

Activities per year

Search results

• SAHMRI Precision Cancer Medicine Theme International Women’s Day Seminar

  Laura Eadie (Speaker)

  8 Mar 2023

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Blood 2022

  Laura Eadie (Speaker)

  11 Sep 2022 → 14 Sep 2022

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• SAHMRI Research Showcase

  Laura Eadie (Speaker)

  15 Nov 2022 → 16 Nov 2022

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• 19th CML Horizons 2021, Medical #2:The future of CML

  Tim Hughes (Invited speaker)

  22 Oct 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Evolving Treatment Paradigm in CML: New Treatment Goals

  Tim Hughes (Invited speaker)

  Feb 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Can the gut microbiota be targeted to enhance immune responses to vaccination?

  David Lynn (Speaker)

  7 Sep 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Blood 2021

  Tim Hughes (Invited speaker)

  20 Sep 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Invited Speaker: RCPA: Introductory Short Course in Genetics and Molecular Pathology

  Deborah White (Invited speaker)

  Nov 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Box Hill Haematology scientific meeting ‘EiNSTEIN’

  Deborah White (Invited speaker)

  Apr 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Drug Discovery and Development SA Symposium

  Deborah White (Invited speaker)

  Mar 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• The 5th Annual Davidoff Hematology International Conference: When Practice Meets Evidence

  Tim Hughes (Invited speaker)

  2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• MEK inhibitors as a targeted therapy approach to overcome resistance in Ph+ ALL cell line with PTPN11 mutations. Poudel G, Asari K, Yeung DT, White DL, Hughes TP, Pagani IS.

  Ilaria Pagani (Speaker)

  2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Mitochondrial DNA mutations are associated with response to imatinib in chronic myeloid leukaemia patients. Pagani IS, Kok CH, Dang P, Lim K, Saunders VA, Hughes M, Kutyna MM, Hiwase DK, Yeung DT, Thomas D, Hughes TP, Ross DM.

  Ilaria Pagani (Speaker)

  2021 → …

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• The impact of glutamine starvation on survival and proliferation in K562 sensitive and imatinib resistant chronic myeloid leukemia cell lines. Hughes M, Saunders V, Hughes TP, Pagani IS.

  Ilaria Pagani (Speaker)

  2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG) Scientific Meeting

  Laura Eadie (Speaker)

  23 Jun 2021 → 25 Jun 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Does the gut microbiota modulate immune responses to vaccination?

  Miriam Lynn (Speaker)

  13 May 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Heamatology Medical Gulf Summit

  Tim Hughes (Invited speaker)

  Feb 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Update on the management of CML in 2021

  Tim Hughes (Invited speaker)

  Feb 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Hemo 2021 – CML / Asciminib Symposium

  Tim Hughes (Invited speaker)

  28 Oct 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• The potential of the gut microbiota to influence immune responses to vaccination.

  David Lynn (Speaker)

  15 Jun 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Novartis GET meeting

  Tim Hughes (Invited speaker)

  Jul 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• John Curtin School of Medical Research Seminar

  Deborah White (Invited speaker)

  Jul 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Mitochondrial DNA mutations are associated with reduced OXPHOS and response to imatinib in chronic myeloid leukaemia patients. Ilaria S Pagani, Chung H Kok, Phuong Dang, Kelly Lim, Verity A Saunders, Madeleine Hughes, David T Yeung, Daniel Thomas, Timothy P Hughes, David M Ross.

  Ilaria Pagani (Speaker)

  2021 → …

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Interrogating the genomic consequences of Ph-like acute lymphoblastic leukaemia in adolescents using single cell mRNAseq.

  Sue Heatley (Speaker)

  11 Mar 2021 → 12 Mar 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Interrogating the genomic consequences of Ph-like acute lymphoblastic leukaemia in adolescents using single cell mRNAseq

  Sue Heatley (Speaker)

  22 Jun 2021 → 25 Jun 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Distinct differences between diagnosis and relapse of Ph-like acute lymphoblastic leukaemia in adolescents are revealed by single cell mRNAseq

  Sue Heatley (Speaker)

  20 Sep 2021 → 23 Sep 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• In-vitro modelling of relapsed, refractory acute lymphoblastic leukaemia from a child with neurofibromatosis.

  Sue Heatley (Speaker)

  20 Sep 2021 → 23 Sep 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Society of Hematologic Oncology 2021 (SOHO)

  Tim Hughes (Invited speaker)

  Sep 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• CML Medical Expert Talk

  Tim Hughes (Invited speaker)

  Feb 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• The gut microbiota mediates the hepatoxicity and cytokine release syndrome induced by immune agonist antibody cancer immunotherapies.

  David Lynn (Speaker)

  30 Jun 2021

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Highlights of ASH in the Mediterranean

  Tim Hughes (Invited speaker)

  Feb 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• CML Management on virtual platform

  Tim Hughes (Invited speaker)

  Jul 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• COVID-19 CML insights

  Tim Hughes (Speaker)

  May 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• EHA MPN-CML Symposium

  Tim Hughes (Invited speaker)

  Jun 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Virtual Presentation on CML to Westmead Hospital

  Tim Hughes (Invited speaker)

  Nov 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Kiwanis Club of Waverley

  Deborah White (Invited speaker)

  Aug 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• The Virtual Congress on Hematology: Age before beauty-an age adjusted approach towards hematological disorders

  Tim Hughes (Invited speaker)

  Oct 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Virtual conference on Treatment Free Remission in CML: from clinical trials to RWE

  Tim Hughes (Invited speaker)

  Nov 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• ABMC Research Mini-Review: Therapeutic triage and risk stratification in leukaemia: the important role of genomics

  Deborah White (Invited speaker)

  Sep 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• BCG and DTPw vaccination induce different programmes of “trained” innate immunity in mice. Optimmunize: Improving the beneficial effects of vaccines

  David Lynn (Speaker)

  19 Feb 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• The gut microbiota influences immune responses systemically in a broad range of contexts

  David Lynn (Speaker)

  24 Feb 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• The choice of treatment in CML

  Tim Hughes (Invited speaker)

  Jul 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• ELN 2020 CML Recommendations

  Tim Hughes (Invited speaker)

  Sep 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Expert Interviews for ASCEMBL Data

  Tim Hughes (Invited speaker)

  Nov 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Society of Hematologic Oncology (SOHO),

  Tim Hughes (Invited speaker)

  Sep 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Kiwanis Childhood Cancer Symposium

  Deborah White (Invited speaker)

  Sep 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• The rate of BCR-ABL1 decline after TKI commencement is a strong predictor of sustained treatment free remission. Shanmuganathan N, Branford S, Pagani IS, Ross, DM, Park S, Yong ASM, Braley J, Altamura H, Hiwase DK, Yeung DT, Kim D-W and Hughes TP.

  Ilaria Pagani (Speaker)

  2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• Understanding the mechanisms of imatinib resistance in a Ph+ acute lymphoblastic leukaemia cell line. Poudel G, Yeung DT, White DL, Hughes TP, Pagani IS.

  Ilaria Pagani (Speaker)

  2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• International Congress of BMT (ICBMT 2020) - satellite symposium

  Tim Hughes (Invited speaker)

  Sep 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

• ALLG: the importance of mRNA Seq in diagnosis, risk stratification and therapeutic triage.

  Deborah White (Invited speaker)

  Nov 2020

  Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks